EWTX
Edgewise Therapeutics, Inc. · Healthcare
Chief Business Officer Behrad Derakhshan sold $200K of Edgewise Therapeutics, Inc.
Sold$200,258
$20.03Price
10,000Shares
−59%Stake
What EWTX did after the filing
- The stock from Fri, Feb 9 close, $19.47
- −17.8%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Mar 25 close.
Traded Wed, Feb 7. Filed Fri, Feb 9, 12:42 PM ET, during the session. Returns use the Feb 9 close and the Mar 25 close. Not investment advice.